Invention Application
- Patent Title: Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells
-
Application No.: US17526951Application Date: 2021-11-15
-
Publication No.: US20220073892A1Publication Date: 2022-03-10
- Inventor: Aamir Mir , Andrew Garst , Stephen Federowicz , Kyle Seamon
- Applicant: Inscripta, Inc.
- Applicant Address: US CO Boulder
- Assignee: Inscripta, Inc.
- Current Assignee: Inscripta, Inc.
- Current Assignee Address: US CO Boulder
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/11 ; C12N15/70 ; C12N15/62
Abstract:
The present disclosure relates to methods and compositions that allow one to identify in vivo edited cells when employing nucleic-acid guided editing. Additionally provided are automated multi-module instruments for performing editing and selection methods and using the compositions.
Public/Granted literature
- US11286471B1 Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells Public/Granted day:2022-03-29
Information query
